Estimates Revisions Revenio Group Oyj
Stocks
REG1V
FI0009010912
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq Helsinki
12:00:00 2026-09-04 EDT
|
After hours 15:59:59 | |||
| 15.68 EUR | -1.01% |
|
15.75 | +0.45% |
| 08-17 | Revenio's iCare DRSplus Included in FDA-Cleared Ai Solution for Diabetic Retinopathy Screening | CI |
| 08-12 | Revenio Group's New CFO to Take Office Later in August | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- REG1V Stock
- Consensus Revenio Group Oyj
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
